Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland
Haloperidol Oral Solution BP 5 mg/5 ml.
| Pharmaceutical Form |
|---|
|
Oral Solution. |
Each 5 ml contains 5 mg of Haloperidol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Haloperidol |
Haloperidol is an antipsychotic belonging to the butyrophenones group. It is a potent central dopamine type 2 receptor antagonist, and at recommended doses, has low alpha-1 antiadrenergic activity and no antihistaminergic or anticholinergic activity. |
| List of Excipients |
|---|
|
Lactic acid |
100 ml, 200 ml and 500 ml type III amber glass bottle with 28 × 18 ROPP LDPE plain white or aluminium cap with EPE (expanded polyethylene) wads and epoxy phenolic lacquer or child resistant closures with expanded polyethylene liners.
100 ml, 200 ml and 500 ml high density polyethylene bottle with 28 mm white polypropylene closure.
Not all pack sizes may be marketed.
Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland
PL 04917/0023
27/02/2007
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
